SCHEDULE: FMR LLC Reports 3.1% Stake in Boston Scientific

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 46,378,258.61 shares of Boston Scientific Corp. common stock, representing 3.1% of the class.

Summary

• FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, indicating their beneficial ownership of Boston Scientific Corp. common stock.
• The total number of shares beneficially owned is 46,378,258.61.
• This holding represents 3.1% of the total outstanding common stock.
• FMR LLC is classified as a holding company (HC), and Abigail P. Johnson is classified as an insider (IN).
• The filing confirms that no single person's interest in the common stock exceeds five percent, excluding investment company shareholders and employee benefit plan beneficiaries.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant but stable institutional holding without new aggressive actions.

Positives

• FMR LLC, a significant institutional investor, maintains a substantial stake in Boston Scientific, suggesting continued confidence in the company's prospects.
• The filing indicates a stable holding, with no indication of aggressive selling or buying activity that might signal a change in strategy.

Negatives

• The filing does not contain any negative financial results or operational challenges.
• There are no indications of management concerns or significant strategic shifts that would be considered negative.

Risks

• The filing does not explicitly mention any new risks or challenges related to Boston Scientific's operations or market position.

Future Outlook

The filing does not contain any forward-looking statements or specific future guidance from the company. It solely reports on current beneficial ownership.

Management Comments

• FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Industry Context

StockSavvy.ai notes that institutional ownership filings like this Schedule 13G are common for large-cap companies like Boston Scientific. The 3.1% stake held by FMR LLC is a significant but not controlling position, typical for diversified investment management firms.

Comparison to Industry Standards

• The 3.1% ownership stake by FMR LLC is within the typical range for institutional investors in the medical device sector. Many large asset managers hold similar or larger stakes in publicly traded healthcare companies.
• Companies like Boston Scientific often have multiple institutional holders with stakes ranging from 1% to over 10%, reflecting broad investor interest in the sector.

Stakeholder Impact

• Shareholders: The continued significant holding by FMR LLC may provide a degree of stability to the stock price, indicating sustained institutional interest.
• Management: The filing confirms that FMR LLC is not seeking to influence control, which is generally viewed positively by current management.

Next Steps

• FMR LLC and Abigail P. Johnson will continue to hold their beneficial ownership of Boston Scientific Corp. common stock.
• Future amendments to this Schedule 13G will be filed if there are material changes in beneficial ownership.

Key Dates

Keywords

Boston Scientific, FMR LLC, Abigail P. Johnson, Schedule 13G, institutional ownership, common stock, beneficial ownership